期刊： VOX SANGUINIS, 2022; 117 (11)
Background and Objectives The chimaerism phenomenon constitutes a significant mechanism underlying ABO phenotype discrepancies; however, its detection......
期刊： VOX SANGUINIS, 2022; 117 (8)
Background and Objectives To advance blood transfusion safety, the Chinese Haemovigilance Network (CHN) was put into operation in 2018. This report de......
期刊： VOX SANGUINIS, 2022; 117 (2)
Background and Objectives The advent of intrauterine transfusion (IUT) has improved the survival of severe foetal anaemia. The aim of this study was t......
期刊： VOX SANGUINIS, 2022; 117 (3)
Background and Objectives: Transfusion-dependent beta-thalassaemia can lead to severe psychological issues in paediatric and adolescent patients. Howe......
期刊： VOX SANGUINIS, 2022; 117 (10)
Background and Objectives Thrombocytopenia is common among sepsis patients. Platelet transfusions are frequently administered to increase platelet cou......
期刊： VOX SANGUINIS, 2022; 117 (5)
Background and Objectives The transfusion of D-negative red blood cells (RBCs) to D-negative patients has been widely adopted to prevent anti-D alloim......
期刊： VOX SANGUINIS, 2022; 117 (5)
Background and Objectives The molecular basis of MNS blood group variants is not fully clear yet. In this study, we have characterized mRNA variants o......
期刊： VOX SANGUINIS, 2022; 117 (7)
Background and Objectives In cases of serologically weak D phenotypes, RHD genotyping may identify discrepant serotyping results and protect the patie......
期刊： VOX SANGUINIS, 2022; 117 (9)
Background and Objectives To assess whether the use of intravenous immunoglobulin (IVIG) in late-preterm and term newborns with haemolytic disease of ......
Background and objectives Haemovigilance involves surveillance of the whole chain of blood transfusion with the aim of identifying adverse events and ......
Background and objectives Thousands of healthcare workers (HCWs) have been infected with 2019 novel coronavirus pneumonia (COVID-19) during the COVID-......
Background Wastage of blood products can be a significant cost to blood banks. However, the cause of wastage is often complex and makes it difficult t......
Background The lack of definitive treatment or preventative options for COVID-19 led many clinicians early on to consider convalescent plasma (CCP) as......
期刊： VOX SANGUINIS, 2021; 116 (1)
Background and objectives COVID-19 convalescent plasma (CCP) has been used, predominantly in high-income countries (HICs) to treat COVID-19; available......
